Quantitative evaluation of oncogenic KRAS signaling and therapeutic effects of molecular-targeted drugs in living cells by single-molecule imaging.

Authors

null

Ryoma Yokoi

Department of Gastroenterological Surgery, Gifu University Hospital, Gifu, Japan

Ryoma Yokoi , Jesse Yu Tajima , Shigeru Kiyama , Yoshihiro Tanaka , Katsutoshi Murase , Manabu Futamura , Kenichi Suzuki , Nobuhisa Matsuhashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Omics for precision medicine

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 76)

DOI

10.1200/JCO.2024.42.23_suppl.76

Abstract #

76

Poster Bd #

E8

Abstract Disclosures